Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.
We developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform.
Our lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide.
- Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies)
- We overcome limitations of several technologies such as mRNA vaccines thanks to our enhanced immunogenicity and standardized GMP manufacturing: we keep control of costs and supply.
Awarded “Best Biotech Startup” in 2024 in France, we recently closed a $25M SERIES A to accelerate our clinical development.
We are currently envisaging clinical collaborations.
Brenus Pharma sets a new paradigm in oncology, by giving back to patients the ability to fight against their disease.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Lyon, Fr
- co****@****rma.com
- Industry
- Biotechnology
- Website
- brenus-pharma.com
- Keywords
- oncology, cancer, immune-therapy, innovation, cell therapy, healthtech, biotech, cancervaccine.
- HQ
- Lyon
Brenus Pharma Questions
Brenus Pharma's website is brenus-pharma.com
Brenus Pharma's LinkedIn profile is https://fr.linkedin.com/company/brenus-pharma
Brenus Pharma has
22 employees.
View email and phone details for 22
employees at Brenus Pharma.
Brenus Pharma's industry is
Biotechnology
Brenus Pharma's top competitors are
Inbolt,
Imadis Groupe,
Orakl Oncology,
Gck,
Huntx Pharma,
May,
Akur8,
Inbrain Pharma,
Nūmi®,
Pony.
Brenus Pharma's support email address is contact@brenus-pharma.com
Brenus Pharma's categories are Biotechnology
Brenus Pharma's founding year is 2019
